Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Bharati J, Bijol V, Salvatore S, Jhaveri KD, Sharma P. The Case | A benign reason behind a malignant finding. Kidney Int. 2023;103(2):433-434.

Saoud C, Lam H, Gross JM, Ali SZ. Fine needle aspiration of bone lesions: A tertiary care centre experience. Cytopathology. 2023;34(6):562-572.

Guadix SW, Garman TS, Gundlach C, Pisapia DJ, Souweidane MM. Durability of an endoscopic management strategy for recurrent choroid plexus carcinoma with a comprehensive molecular characterization: illustrative case. J Neurosurg Case Lessons. 2023;5(10).

Nguyen-Dien GT, Kozul K-, Cui Y, Townsend B, Kulkarni PG, Ooi SS, et al. FBXL4 suppresses mitophagy by restricting the accumulation of NIX and BNIP3 mitophagy receptors. EMBO J. 2023;42(13):e112767.

Chaudagar K, Hieromnimon HM, Kelley A, Labadie B, Shafran J, Rameshbabu S, et al. Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosis. bioRxiv. 2023.

Vohra AS, Johannesen J, Jessurun J, Weinsaft JW, Singh HS, Cheung JW, et al. A mimicker of constriction: a case report of a rare case of cardiac angiosarcoma. Eur Heart J Case Rep. 2023;7(6):ytad260.

Toejing P, Sakunrangsit N, Pho-On P, Phetkong C, Leelahavanichkul A, Sridurongrit S, et al. Accelerated Bone Loss in Transgenic Mice Expressing Constitutively Active TGF-β Receptor Type I. Int J Mol Sci. 2023;24(13).

Martinez-Ordoñez A, Cid-Diaz T, Duran A, Han Q, Moscat J, Diaz-Meco MT. Whole-mount staining of mouse colorectal cancer organoids and fibroblast-organoid co-cultures. STAR Protoc. 2023;4(2):102243.

Chadburn A. Post-transplant lymphoproliferative disorders (PTLD) in adolescents and young adults: A category in need of definition. Semin Diagn Pathol. 2023;40(6):401-407.

Zeng X, Yang M, Ye T, Feng J, Xu X, Yang H, et al. Mitochondrial GRIM-19 loss in parietal cells promotes spasmolytic polypeptide-expressing metaplasia through NLR family pyrin domain-containing 3 (NLRP3)-mediated IL-33 activation via a reactive oxygen species (ROS) -NRF2- Heme oxygenase-1(HO-1)-NF-кB axis. Free Radic Biol Med. 2023;202:46-61.